Alembic Pharma receives USFDA nod for Pregabalin capsules

Alembic Pharmaceuticals Limited announced that it has received PAS (Prior Approval Supplement) approval from the US Food Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) Pregabalin capsules, 25 mg, 50 mg,...

BeatO appoints Dr Navneet Agrawal as chief clinical officer

BeatO, a comprehensive digital diabetes care platform for controlling and reversing diabetes, has announced the appointment of Dr. Navneet Agrawal as its chief clinical officer. Dr. Navneet Agrawal will head BeatO’s proprietary Diabetes Care...

C-CAMP & Netherlands Embassy in India launch WAH! Accelerator to fulfil the One Health Vision to address AMR

Centre for Cellular and Molecular Platforms (C-CAMP) an initiative supported by Department of Biotechnology is delighted to announce a next-generation Indo-Dutch bilateral collaboration to address the challenge posed by antimicrobial resistance...

All India Institute of Ayurveda organises National Workshop on Ayurveda Nephrology

The All India Institute of Ayurveda has organised a national workshop today on Ayurveda Nephorology - Vrikka Sambhashna...

Guerison expands into the Indian ophthalmology market

Guerison, a global pharmaceutical company having a surgical business in Dubai, is setting its footprints in India’s ophthalmology market with the highest ethics, top development, and utmost safety standards...

EnginZyme raises 21 million in Series B to amplify the commercialisation of its cell-free biomanufacturing technology

EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced that it had raised €21 million in a Series B financing round...

Global Pharmaceutical Company Dr Reddy's completes phase 1 study of DRL_TC, proposed biosimilar of tocilizumab

Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, announced that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in a phase 1 study. This phase 1 study used a subcutaneous formulation...

Leading care Hospital Apollo opens a stoma clinic and colorectal cancer support group

Apollo Hospitals, a leading quaternary care hospital, has launched a dedicated free support group and helpline number to support those with colorectal cancer and a stoma clinic....

Clariant to invest CHF 80 million to expand Chinese ethoxylation plant

Clariant is set to expand its Care Chemicals facility in Daya Bay, Huizhou, China, to boost its support for pharmaceutical, personal care, home care, and industrial application customers...

Everest Medicines achieves preclinical proof-of-concept milestone for its mRNA rabies vaccine programme

Everest Medicines, a biopharmaceutical company, announced that the company has achieved the preclinical proof-of-concept milestone for its mRNA rabies vaccine programme. This new vaccine candidate for rabies post-exposure prophylactic was...

© 2025 India Pharma Outlook. All Rights Reserved.